Anúncio
Anúncio
MIRA
MIRA Pharmaceuticals, Inc. Common Stock
1.49
USDPatrocinado
0.00
-0.34%
09 de jan., 15:56 UTC -5
Encerrado
Pós-Mercado
1.49
0.00
0.00%
Relatórios de Lucros MIRA
Rácio de surpresa positiva
MIRA separação 5 de 8 últimas estimativas.
63%
Próximo Relatório
Data do Próximo Relatório
15 de abr. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.04
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-33.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-73.33%
MIRA Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 13 de nov. de 2025, MIRA reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.08 USD, resulting in a 26.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.04 USD, with revenue projected to reach -- USD, implying an diminuir of -33.33% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were MIRA Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MIRA Pharmaceuticals, Inc. Common Stock reported EPS of -$0.06, beating estimates by 26.47%, and revenue of $0.00, 0% as expectations.
How did the market react to MIRA Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -6.29%, changed from $1.43 before the earnings release to $1.34 the day after.
When is MIRA Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 15 de abr. de 2026.
What are the forecasts for MIRA Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 3
analistas, MIRA Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.04 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio